Evidence map›Paper›PMID 40344651›Full record

ArticlePhysical therapy2025

Primary Care Physical Therapy and Exercise Therapy for People With Persistent Complaints After a SARS-CoV-2 Infection: Secondary Analysis of the ParaCov Prospective Cohort Study.

Marissa H G Gerards, Arie C Verburg, Anne I Slotegraaf, Ron van Heerde, Rob A de Bie, Philip J van der Wees, Antoine F Lenssen, Thomas J Hoogeboom, Dutch Consortium Allied Healthcare COVID-19

Abstract read
In one paragraph

Article in Physical therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marissa H G GerardsDepartment of Epidemiology, Care and Public Health Institute (CAPHRI), Faculty of Health, Medicine and Life Sciences, Maastricht University, 6229 HA Maastricht, Limburg, The Netherlands.ORCID 0000-0001-7388-2356
Arie C VerburgIQ Health, Radboud University Medical Center, 6525 EP Nijmegen, Gelderland, The Netherlands.ORCID 0000-0003-4068-8228
Anne I SlotegraafDivision of Human Nutrition and Health, Wageningen University and Research, 6708PB Wageningen, Gelderland, The Netherlands.ORCID 0000-0001-7162-5348
Ron van HeerdeIQ Health, Radboud University Medical Center, 6525 EP Nijmegen, Gelderland, The Netherlands.ORCID 0000-0001-7273-0879
Rob A de BieDepartment of Epidemiology, Care and Public Health Institute (CAPHRI), Faculty of Health, Medicine and Life Sciences, Maastricht University, 6229 HA Maastricht, Limburg, The Netherlands.ORCID 0000-0001-5882-9303
Philip J van der WeesIQ Health, Radboud University Medical Center, 6525 EP Nijmegen, Gelderland, The Netherlands.ORCID 0000-0003-2881-5159
Antoine F LenssenDepartment of Physiotherapy, Maastricht University Medical Center, 6229 ET Maastricht, Limburg, The Netherlands.ORCID 0000-0003-3627-4452
Thomas J HoogeboomIQ Health, Radboud University Medical Center, 6525 EP Nijmegen, Gelderland, The Netherlands.ORCID 0000-0003-2103-419X
Dutch Consortium Allied Healthcare COVID-19

Funding

Maastricht UniversityNivel Netherlands Institute for Health Services ResearchStichting Revalidatie en Wetenschapthe Association for Quality in Physical Therapythe Royal Dutch Society for PhysiotherapyZonMw Efficiency Studies 10390062010001
6 · The paper itself

Abstract

importanceCurrent insight into recovery and real-world treatment of people with persistent complaints after SARS-CoV-2 infection is limited.

objectiveThe objective of this study was to describe the content, duration, and reasons for initiating and terminating physical therapist interventions and (factors contributing to) changes in outcomes before and after treatment.

designThis was a prospective cohort study in Dutch primary care allied health care.

participantsParticipants were patients receiving allied health care treatment after SARS-CoV-2 infection.

interventionThe intervention was primary care physical therapy. MAIN OUTCOMES AND MEASURES: Self-reported functioning (patient-specific functional scale [PSFS]), 6-min walk test (6MWT), sit-to-stand performance (5 times sit-to-stand [5TSTS]), grip strength, and treatment characteristics were measured pre- and post-treatment. Associations between baseline characteristics, pre-treatment scores, and clinically important improvement on PSFS were calculated.

resultsNine hundred ninety-two patients (mean age 50 years [SD = 13]) were included. Median treatment duration was 24 weeks (IQR = 17-26) and 31 sessions (19-43). Most selected treatment goals were to improve endurance (74%) and physical functioning (72%). In 59% of treatment episodes, therapists reported that patients had achieved the main treatment goal. Mean change scores (95% CIs) were -4.1 points (-4.4 to -3.8) on the PSFS, 70 m (61-78) on the 6MWT, -3.0 s (-3.4 to -2.5) on the 5TSTS, and 3.0 kg (2.1-3.9) on grip strength. Females and participants with worse baseline scores on PSFS had greater odds of reporting a clinically important improvement on the PSFS. Patients with longer 5TSTS times had lower odds.

conclusionMost patients achieved their treatment goals and demonstrated clinically important improvements on PSFS and 6MWT. This study provides information on the most important therapeutic goals and provides estimates for realistic treatment episodes. RELEVANCE: This article provides insight into real-world physical therapy in patients experiencing persistent complaints after SARS-CoV-2 infection. Additionally, insight into their recovery is provided, showing that patients improve significantly and clinically important on self-reported functioning, 6-min walk test, and sit-to-stand performance.

Indexed as

COVID-19Exercise TherapyPhysical Therapy ModalitiesPrimary Health CareAdultAgedFemaleHand StrengthHumansMaleMiddle AgedNetherlandsProspective StudiesSARS-CoV-2Walk TestCovid-19Exercise TherapyPhysical TherapyPrimary CareRecoveryRehabilitation

Identifiers

PMID40344651
PMCPMC12202032

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.